Provided by Tiger Fintech (Singapore) Pte. Ltd.

Baxter

28.62
+0.08000.28%
Post-market: 28.620.00000.00%19:00 EDT
Volume:4.60M
Turnover:132.24M
Market Cap:14.68B
PE:-22.49
High:29.14
Open:28.89
Low:28.50
Close:28.54
Loading ...

Baxter International Is Maintained at Neutral by JP Morgan

Dow Jones
·
21 Feb

Palantir initiated, Roku upgraded: Wall Street’s top analyst calls

TipRanks
·
21 Feb

Company News for Feb 21, 2025

Zacks
·
21 Feb

Jefferies Adjusts Baxter International's Price Target to $38 From $39

MT Newswires Live
·
21 Feb

Baxter International’s 2025 Outlook: Hold Rating Amid Growth Potential and Leadership Transition

TIPRANKS
·
21 Feb

Baxter International Inc (BAX) Q4 2024 Earnings Call Highlights: Strong EPS Growth and ...

GuruFocus.com
·
21 Feb

Q4 2024 Baxter International Inc Earnings Call

Thomson Reuters StreetEvents
·
21 Feb

Stock Track | Baxter Soars 8.24% on Strong Q4 Results, Robust 2025 Outlook

Stock Track
·
20 Feb

Stock Track | Baxter Surges 6.42% Pre-Market as Q4 Results Beat Estimates, 2025 Outlook Robust

Stock Track
·
20 Feb

Baxter Expects Q1 2025 Adjusted EPS Of $0.47-$0.50 Versus Consensus Of $0.52, With Sales Growth Of 3%-4% On Reported Basis And Approximately 4% On Operational Basis

Benzinga
·
20 Feb

Baxter Expects 2025 Adjusted EPS Of $2.45-$2.55 Versus Consensus Of $2.47, With Sales Growth Of 5%-6% On Reported Basis And 4%-5% On Organic Basis

Benzinga
·
20 Feb

Baxter Intl Q4 2024 Adj EPS $0.58 Beats $0.52 Estimate, Sales $2.75B Beat $2.67B Estimate

Benzinga
·
20 Feb

BRIEF-Baxter Q4 Adjusted EPS USD 0.77 Vs. IBES Estimate USD 0.52

Reuters
·
20 Feb

Baxter: Q4 Results Include Special Items of $908 Mln After-Tax, Primarily Related to Impact of Front Line Care Goodwill Impairment Charge and Others

THOMSON REUTERS
·
20 Feb

Baxter: North Cove Is NOW Producing at Pre-Hurricane Levels

THOMSON REUTERS
·
20 Feb

Baxter International Inc Q1 Shr View $0.51, REV View $2.63 Bln -- Lseg Ibes Data

THOMSON REUTERS
·
20 Feb

Baxter: Outlook FY Adj Earnings From Continuing Operations, Before Special Items, of $2.45 to $2.55 per Share

THOMSON REUTERS
·
20 Feb

Baxter Outlook Q1 Sales Growth From Continuing Operations of 3% to 4% on a Reported Basis & About 4% on an Operational Basis

THOMSON REUTERS
·
20 Feb

Baxter: Transformative Sale of Kidney Care Business NOW Complete

THOMSON REUTERS
·
20 Feb

Baxter Outlook FY Revenue Growth 5-6%

THOMSON REUTERS
·
20 Feb